Mahmut Gümüş – President, Turkish Society of Medical Oncology, Turkey

Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the healthcare sector. However, he has high hopes that the country will continue to prioritize oncology as a key therapeutic area to invest in, thorough increasing specialists, ultimately giving the country’s oncology patients the best quality of life possible. In a recent interview, you commented that cancer incident rates in Turkey are above the world average but below that of other European Countries. What is your overall assessment of oncology in Turkey?
"In public institutions and private hospitals, oncological surgical procedure fees have been increased by the amount paid by the social security institution. However, these amounts may not be sufficient for a quality service delivery."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report